Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan

Int J Med Sci. 2022 May 29;19(6):1013-1022. doi: 10.7150/ijms.72378. eCollection 2022.

Abstract

Single nucleotide polymorphisms (SNPs) of tissue inhibitor of metalloproteinases-3 (TIMP-3) have been revealed to be related to various cancers. To date, no study explores the relationships between TIMP-3 polymorphisms and uterine cervical cancer. The purposes of this research were to investigate the associations among genetic variants of TIMP-3 and development and clinicopathological factors of uterine cervical cancer, and patient 5 years survival in Taiwanese women. The study included 123 patients with invasive cancer and 97 with precancerous lesions of uterine cervix, and 300 control women. TIMP-3 polymorphisms rs9619311, rs9862 and rs11547635 were checked and their genotypic distributions were determined by real-time polymerase chain reaction. It showed that women with genotypes CT/TT in rs9862 were found to display a higher risk of developing cervical cancer with moderate and poor cell differentiation. Moreover, it revealed that cervical cancer patients carrying genotypes CC in rs9619311 exhibited a poorer 5 years survival, as compared to those with TT/TC in Taiwanese women, using univariate analysis. In addition, pelvic lymph node metastasis was determined to independently predict 5 years survival in cervical cancer patients using multivariate analysis. Conclusively, TIMP-3 SNPs polymorphisms rs9619311 are related to cervical patient survival in Taiwanese women.

Keywords: 5 years survival; lymph node metastasis; single nucleotide polymorphisms; tissue inhibitor of metalloproteinases-3; uterine cervical cancer.

MeSH terms

  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Polymorphism, Single Nucleotide / genetics
  • Taiwan / epidemiology
  • Tissue Inhibitor of Metalloproteinase-3 / genetics
  • Uterine Cervical Neoplasms* / genetics
  • Uterine Cervical Neoplasms* / mortality
  • Uterine Cervical Neoplasms* / pathology

Substances

  • TIMP3 protein, human
  • Tissue Inhibitor of Metalloproteinase-3